RPLP0 and neoplasm: Compared with tumor tissues from patients sensitive to radiochemotherapy (TRG0, tumor regression grades 0), both NONO and RPLP0 proteins were highly expressed in that from resistant patients (TRG3) (Fig. 6D and Fig. S5).